Browsing: Network

The rising complexity of clinical trials, combined with pressures resulting from the COVID-19 pandemic, have forced sites, sponsors, and clinical research organizations (CROs) to adopt remote and risk-based approaches for clinical trial execution to ensure the safety of trial participants, maintain compliance with good clinical practice, and minimize risks to trial integrity.

In 2020, after the COVID-19 pandemic surfaced, the need for alternative approaches to clinical trial execution and data capture became a reality overnight. The concept of implementing components of decentralization within a clinical trial became one of ‘here and now,’ versus a concept of the future. In many instances, the pandemic halted the patient’s ability to go to a site.

What was once an emergent market trend is now an established market need: decentralized clinical trial technology. Decentralized clinical trials, also known as virtual or hybrid trials, were already increasingly appealing, but as of late there has been a rapid acceleration in decentralized trial technology adoption.

IT- och säkerhetsteamen på alla företag har länge prioriterat att skydda och förhindra förlust av känslig information. Men nu när folk, enheter och appar tar sig långt utanför det traditionella kontorets gränser omprövar informationschefen och informationssäkerhetschefen synen på informationsskydd och de verktyg de behöver för att säkra och förhindra missbruk av känsliga data.

Global organizations are managing ongoing pandemic-related challenges—supply chain issues, worker shortages, and the continued need to respond to changing regulatory health and safety mandates. Businesses across industries are moving forward, leveraging technology to rebuild customer relationships, automate and streamline business processes, and increase revenue.